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Sialic acid, a post-translational modification, is an important product quality attribute of 
glycoproteins.  The levels of sialic acid may impact solubility of the final product and the half-
life (product clearance).  In addition, the N-glycolylneuraminic acid (NGNA) form of sialic acid 
may elicit an immunogenic response in humans.  In an effort to have a more high-throughput 
evaluation of these product quality attributes, two plate based assays were developed.   
Specifically, a direct NGNA ELISA was developed using a polyclonal chicken anti-
NGNA antibody.  This assay was implemented as one of the clone screening tools to eliminate 
clones that may produce more of the immunogenic sialic acid.  In addition, the assay was 
developed using both purified materials and harvest cell culture fluid (HCCF), thereby 
eliminating the need for downstream processing and enabling high-throughput of samples.  The 
results of the assay were verified using the more traditional Dionex method. 
The second assay developed was a fluorescence based plate assay to measure total sialic 
acid levels on our protein of interest.  During early stage process development, different culture 
conditions resulted in varying levels of total sialic acid on the final product.  This assay was used 
to monitor the impact of changes in media/feed components and operation parameters on total 
sialic acid levels.  Although results of this plate based assay from purified material gave the same 
ranking as those from the Dionex method, assays performed with HCCF gave much higher 
background values.  Therefore, a high-throughput resin plate method of purification to provide 
suitable and representative samples was established.  The purity of these one step purified 
materials were > 80% and the assay results were in line with the traditional methods. 
Using both of the assays developed ensured we established a cell line and upstream 
process that produced a protein with the desired quality of sialic acid content, while minimizing 
the potentially immunogenic NGNA. 
 
